Stocks and Investing
by (remove) : Andrea Tan
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Andrea Tan
RSS • JSON • XML • CSV

Andrea Tan Initiated (ARWR) at Hold and Held Target at $31 on, Jun 5th, 2024


Published on 2024-10-28 11:48:28 - WOPRAI, Andrea Tan
  Print publication without navigation


Andrea Tan of Goldman Sachs, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $31 on, Jun 5th, 2024.

Andrea has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Andrea's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024
  • Shawn Egan of "Citigroup" Maintained at Hold with Increased Target to $34 on, Wednesday, February 7th, 2024


These are the ratings of the 3 analyists that currently disagree with Andrea

  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Monday, June 3rd, 2024
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $50 on, Wednesday, February 7th, 2024
Contributing Sources